Corestreet Logo

Neurocrine Biosciences Inc (NBIX) Insider Trading

Total insider buys:
  • $39,032,821.44
Total insider sells:
  • $380,590,314.37
Most recent insider trade:
  • Feb. 13, 2025
Most active insider trader:
  • Kevin Charles Gorman
Trader NameDateTitleAmountPriceTypeTotal Value
June 27, 2022Insider754$100.00Sell$75,400.00
May 9, 2022Director15,000$76.30Sell$1,144,500.00
April 25, 2022Director15,000$92.76Sell$1,391,400.00
April 1, 2022Director10,728$94.93Sell$1,018,409.04
March 22, 2022Insider8,455$95.05Sell$803,647.75
March 18, 2022Insider300$95.00Sell$28,500.00
Feb. 7, 2022CEO8,710$80.82Sell$703,942.20
Feb. 7, 2022Insider240$81.07Sell$19,456.80
Feb. 7, 2022CFO3,310$80.79Sell$267,414.90
Jan. 24, 2022Director15,000$74.43Sell$1,116,450.00
Jan. 10, 2022Insider2,632$74.50Sell$196,084.00
Jan. 5, 2022Insider28,266$85.50Sell$2,416,743.00
Dec. 1, 2021CFO1,645$82.59Sell$135,860.55
Oct. 7, 2021Director5,000$105.06Sell$525,300.00
Oct. 7, 2021Insider8,000$104.81Sell$838,480.00
Oct. 4, 2021Insider987$101.73Sell$100,407.51
Aug. 16, 2021Insider5,628$89.62Sell$504,381.36
July 27, 2021Insider16,709$93.80Sell$1,567,304.20
June 10, 2021Director10,000$100.27Sell$1,002,700.00
Feb. 10, 2021Insider1,700$119.96Sell$203,932.00
Feb. 8, 2021CFO2,910$116.82Sell$339,946.20
Feb. 8, 2021CEO10,466$116.75Sell$1,221,905.50
Feb. 8, 2021Insider2,363$116.78Sell$275,951.14
Feb. 5, 2021Insider865$114.15Sell$98,739.75
Feb. 5, 2021CEO2,422$114.16Sell$276,495.52
Jan. 26, 2021Insider1,100$119.97Sell$131,967.00
Jan. 25, 2021Director1,600$120.03Sell$192,048.00
Jan. 8, 2021CEO308,250$110.22Sell$33,975,315.00
Jan. 8, 2021Insider2,632$111.06Sell$292,309.92
Dec. 1, 2020CFO1,645$94.66Sell$155,715.70
Nov. 12, 2020CEO3,390$90.78Sell$307,744.20
Nov. 12, 2020Insider2,257$90.71Sell$204,732.47
Nov. 2, 2020Insider20,595$96.53Sell$1,988,035.35
Oct. 2, 2020Insider987$95.26Sell$94,021.62
Aug. 5, 2020CEO3,390$118.91Sell$403,104.90
Aug. 5, 2020Insider2,257$118.84Sell$268,221.88
July 9, 2020Insider1,657$136.02Sell$225,385.14
June 23, 2020Insider5,000$130.00Sell$650,000.00
May 18, 2020Insider5,000$120.00Sell$600,000.00
May 12, 2020Insider61,555$114.94Sell$7,075,131.70
May 7, 2020Insider8,682$105.44Sell$915,430.08
May 7, 2020CFO15,000$110.21Sell$1,653,150.00
April 28, 2020Director17,687$99.39Sell$1,757,910.93
April 28, 2020CFO1,741$102.49Sell$178,435.09
April 24, 2020CEO2,906$99.45Sell$289,001.70
April 24, 2020Insider1,934$99.47Sell$192,374.98
April 15, 2020Insider8,632$94.65Sell$817,018.80
Feb. 10, 2020Insider28,969$104.56Sell$3,028,998.64
Feb. 7, 2020Insider1,623$103.31Sell$167,672.13
Feb. 7, 2020CEO3,248$103.35Sell$335,680.80
First«3 of 7»Last

  • Insiders are both buying and selling Neurocrine Biosciences Inc stock.

  • The insider traders at Neurocrine Biosciences Inc are: Kevin Charles Gorman, Gary A Lyons, Darin Lippoldt, Haig P Bozigian, Dimitri E Grigoriadis, Matt Abernethy, Christopher Flint Obrien, Eiry Roberts, Eric Benevich, Timothy P Coughlin, Kyle Gano, Julie Cooke, Ingrid Delaet, Malcolm Lloyd-Smith, William H Rastetter, Richard F Pops, David W Boyer, Stephen A Sherwin, W Thomas Mitchell, Timothy Coughlin, Corinne H Nevinny, Jude Onyia, Haig Bozigian, Dimitri Grigoriadis, Neurocrine Biosciences Inc, Shalini Sharp, Leslie V. Norwalk, Dimitri E. Grigoriadis, Gary A. Lyons, George J. Morrow, and Haig P. Bozigian

  • The most active insider trader at Neurocrine Biosciences Inc is Kevin Charles Gorman with 45 trades.

  • Kevin Charles Gorman has sold the most Neurocrine Biosciences Inc stock with a total value of $122,380,811.88.

  • Neurocrine Biosciences Inc has bought the most Neurocrine Biosciences Inc stock with a total value of $78,065,642.88.

  • The most recent insider trade for Neurocrine Biosciences Inc was on Feb. 13, 2025.

  • The single biggest insider buy for Neurocrine Biosciences Inc was from Neurocrine Biosciences Inc with a total value of $39,032,821.44 on Feb. 23, 2023.

  • The single biggest insider sell for Neurocrine Biosciences Inc was from Kevin Charles Gorman with a total value of $33,975,315.00 on Jan. 8, 2021.